Skip to main content
Top
Published in: Inflammation 5/2017

Open Access 01-10-2017 | ORIGINAL ARTICLE

Role of Oxidative Stress in the Suppression of Immune Responses in Peripheral Blood Mononuclear Cells Exposed to Combustible Tobacco Product Preparation

Authors: Subhashini Arimilli, Eckhardt Schmidt, Brad E. Damratoski, G. L. Prasad

Published in: Inflammation | Issue 5/2017

Login to get access

Abstract

Cigarette smoking is a major risk factor for several human diseases. Chronic inflammation, resulting from increased oxidative stress, has been suggested as a mechanism that contributes to the increased susceptibility of smokers to cancer and microbial infections. We have previously shown that whole-smoke conditioned medium (WS-CM) and total particulate matter (TPM) prepared from Kentucky 3R4F reference cigarettes [collectively called as combustible tobacco product preparations (TPPs)] potently suppressed agonist-stimulated cytokine secretion and target cell killing in peripheral blood mononuclear cells (PBMCs). Here we have investigated the role of oxidative stress from TPPs, which alters inflammatory responses in vitro. Particularly, we investigated the mechanisms of WS-CM-induced suppression of select cytokine secretions in Toll-like receptor (TLR) agonist-stimulated cells and target cell killing by effector cells in PBMCs. Pretreatment with N-acetyl cysteine (NAC), a precursor of reduced glutathione and an established anti-oxidant, protected against DNA damage and cytotoxicity caused by exposure to WS-CM. Similarly, secretion of tumor necrosis factor (TNF), interleukin (IL)-6, and IL-8 in response to TLR-4 stimulation was restored by pretreatment with NAC. Target cell killing, a functional measure of cytolytic cells in PBMCs, is suppressed by WS-CM. Pretreatment with NAC restored the target cell killing in WS-CM treated PBMCs. This was accompanied by higher perforin levels in the effector cell populations. Collectively, these data suggest that reducing oxidative stress caused by cigarette smoke components restores select immune responses in this ex vivo model.
Literature
1.
go back to reference US Department of Health and Human Services. 2010. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease, a report of the surgeon general. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. US Department of Health and Human Services. 2010. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease, a report of the surgeon general. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
2.
go back to reference Perfetti, T.A. 2011. The complexity of tobacco and tobacco smoke. Beiträge zur Tabakforschung International 24 (5): 215–232. Perfetti, T.A. 2011. The complexity of tobacco and tobacco smoke. Beiträge zur Tabakforschung International 24 (5): 215–232.
4.
go back to reference Mehta, H., K. Nazzal, and R.T. Sadikot. 2008. Cigarette smoking and innate immunity. Inflammation Research 57 (11): 497–503.CrossRefPubMed Mehta, H., K. Nazzal, and R.T. Sadikot. 2008. Cigarette smoking and innate immunity. Inflammation Research 57 (11): 497–503.CrossRefPubMed
5.
go back to reference Feng, Y., et al. 2011. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infection and Immunity 79 (1): 229–237.CrossRefPubMed Feng, Y., et al. 2011. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infection and Immunity 79 (1): 229–237.CrossRefPubMed
6.
go back to reference Johnson, M.D., et al. 2009. Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiology, Biomarkers & Prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18 (12): 3263–3304.CrossRef Johnson, M.D., et al. 2009. Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiology, Biomarkers & Prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18 (12): 3263–3304.CrossRef
7.
go back to reference Fukano, Y., et al. 2004. Modified procedure of a direct in vitro exposure system for mammalian cells to whole cigarette smoke. Experimental and Toxicologic Pathology 55 (5): 317–323.CrossRefPubMed Fukano, Y., et al. 2004. Modified procedure of a direct in vitro exposure system for mammalian cells to whole cigarette smoke. Experimental and Toxicologic Pathology 55 (5): 317–323.CrossRefPubMed
8.
go back to reference Arimilli, S., et al. 2012. Evaluation of cytotoxicity of different tobacco product preparations. Regulatory Toxicology and Pharmacology 64 (3): 350–360.CrossRefPubMed Arimilli, S., et al. 2012. Evaluation of cytotoxicity of different tobacco product preparations. Regulatory Toxicology and Pharmacology 64 (3): 350–360.CrossRefPubMed
9.
go back to reference Lu, B., et al. 2007. Cytotoxicity and gene expression profiles in cell cultures exposed to whole smoke from three types of cigarettes. Toxicological Sciences 98 (2): 469–478.CrossRefPubMed Lu, B., et al. 2007. Cytotoxicity and gene expression profiles in cell cultures exposed to whole smoke from three types of cigarettes. Toxicological Sciences 98 (2): 469–478.CrossRefPubMed
10.
go back to reference Gao, H., G.L. Prasad, and W. Zacharias. 2013. Differential cell-specific cytotoxic responses of oral cavity cells to tobacco preparations. Toxicology In Vitro 27 (1): 282–291.CrossRefPubMed Gao, H., G.L. Prasad, and W. Zacharias. 2013. Differential cell-specific cytotoxic responses of oral cavity cells to tobacco preparations. Toxicology In Vitro 27 (1): 282–291.CrossRefPubMed
11.
go back to reference Ngkelo, A., et al. 2012. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Gia dependent PI-3kinase signalling. Journal of Inflammation 9 (1): 1–1.CrossRefPubMedPubMedCentral Ngkelo, A., et al. 2012. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Gia dependent PI-3kinase signalling. Journal of Inflammation 9 (1): 1–1.CrossRefPubMedPubMedCentral
12.
go back to reference Arimilli, S., B.E. Damratoski, and G.L. Prasad. 2013. Combustible and non-combustible tobacco product preparations differentially regulate human peripheral blood mononuclear cell functions. Toxicology in Vitro : an international journal published in association with BIBRA 27 (6): 1992–2004.CrossRef Arimilli, S., B.E. Damratoski, and G.L. Prasad. 2013. Combustible and non-combustible tobacco product preparations differentially regulate human peripheral blood mononuclear cell functions. Toxicology in Vitro : an international journal published in association with BIBRA 27 (6): 1992–2004.CrossRef
13.
go back to reference Chen, H., et al. 2007. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. Journal of Immunology 179 (9): 6097–6106.CrossRef Chen, H., et al. 2007. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. Journal of Immunology 179 (9): 6097–6106.CrossRef
14.
go back to reference Goncalves, R.B., et al. 2011. Impact of smoking on inflammation: overview of molecular mechanisms. Inflammation Research 60 (5): 409–424.CrossRefPubMed Goncalves, R.B., et al. 2011. Impact of smoking on inflammation: overview of molecular mechanisms. Inflammation Research 60 (5): 409–424.CrossRefPubMed
15.
go back to reference Yao, H., and I. Rahman. 2011. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicology and Applied Pharmacology 254 (2): 72–85.CrossRefPubMedPubMedCentral Yao, H., and I. Rahman. 2011. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicology and Applied Pharmacology 254 (2): 72–85.CrossRefPubMedPubMedCentral
16.
go back to reference Sundar, I.K., H. Yao, and I. Rahman. 2013. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxidants & Redox Signaling 18 (15): 1956–1971.CrossRef Sundar, I.K., H. Yao, and I. Rahman. 2013. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxidants & Redox Signaling 18 (15): 1956–1971.CrossRef
18.
go back to reference Carnevali, S., et al. 2003. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. American Journal of Physiology-Lung Cellular and Molecular Physiology 284 (6): L955–L963.CrossRefPubMed Carnevali, S., et al. 2003. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. American Journal of Physiology-Lung Cellular and Molecular Physiology 284 (6): L955–L963.CrossRefPubMed
19.
go back to reference De Flora, S., et al. 1995. Mechanisms of anticarcinogenesis: the example of N-acetylcysteine. In Drugs, diet and diseases. Mechanistic approach to cancer, ed. C. Ioannides and D. Lewis, 151–203. Hemel Hempstead: Horwood Ellis. De Flora, S., et al. 1995. Mechanisms of anticarcinogenesis: the example of N-acetylcysteine. In Drugs, diet and diseases. Mechanistic approach to cancer, ed. C. Ioannides and D. Lewis, 151–203. Hemel Hempstead: Horwood Ellis.
20.
go back to reference Groskreutz, D.J., et al. 2009. Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. American Journal of Respiratory Cell and Molecular Biology 41 (2): 189–198.CrossRefPubMedPubMedCentral Groskreutz, D.J., et al. 2009. Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. American Journal of Respiratory Cell and Molecular Biology 41 (2): 189–198.CrossRefPubMedPubMedCentral
21.
go back to reference Kar Mahapatra, S., et al. 2011. Alteration of immune functions and Th1/Th2 cytokine balance in nicotine-induced murine macrophages: immunomodulatory role of eugenol and N-acetylcysteine. International Immunopharmacology 11 (4): 485–495.CrossRefPubMed Kar Mahapatra, S., et al. 2011. Alteration of immune functions and Th1/Th2 cytokine balance in nicotine-induced murine macrophages: immunomodulatory role of eugenol and N-acetylcysteine. International Immunopharmacology 11 (4): 485–495.CrossRefPubMed
22.
go back to reference Zafarullah, M., et al. 2003. Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences CMLS 60 (1): 6–20.CrossRefPubMed Zafarullah, M., et al. 2003. Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences CMLS 60 (1): 6–20.CrossRefPubMed
23.
go back to reference De Flora, S., et al. 2001. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22 (7): 999–1013.CrossRefPubMed De Flora, S., et al. 2001. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22 (7): 999–1013.CrossRefPubMed
24.
go back to reference Khanna, A.K., J. Xu, and M.R. Mehra. 2012. Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model. Laboratory Investigation; a journal of technical methods and pathology 92 (2): 224–235.CrossRefPubMed Khanna, A.K., J. Xu, and M.R. Mehra. 2012. Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model. Laboratory Investigation; a journal of technical methods and pathology 92 (2): 224–235.CrossRefPubMed
25.
go back to reference Balansky, R., et al. 2010. Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine. International Journal of Cancer 126 (5): 1047–1054.PubMedPubMedCentral Balansky, R., et al. 2010. Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine. International Journal of Cancer 126 (5): 1047–1054.PubMedPubMedCentral
26.
go back to reference Sadowska, A.M., Y.K.B. Manuel, and W.A. De Backer. 2007. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulmonary Pharmacology & Therapeutics 20 (1): 9–22.CrossRef Sadowska, A.M., Y.K.B. Manuel, and W.A. De Backer. 2007. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulmonary Pharmacology & Therapeutics 20 (1): 9–22.CrossRef
27.
go back to reference Arimilli, S., et al. 2012. Rapid isolation of leukocyte subsets from fresh and cryopreserved peripheral blood mononuclear cells in clinical research. CryoLetters 33 (5): 376–384.PubMed Arimilli, S., et al. 2012. Rapid isolation of leukocyte subsets from fresh and cryopreserved peripheral blood mononuclear cells in clinical research. CryoLetters 33 (5): 376–384.PubMed
28.
go back to reference Arimilli, S., B.E. Damratoski, and L.P. G. 2015. Methods to evaluate cytotoxicity and immunosuppression of combustible tobacco product preparations. Journal of Visualized Experiments 95: 52351. Arimilli, S., B.E. Damratoski, and L.P. G. 2015. Methods to evaluate cytotoxicity and immunosuppression of combustible tobacco product preparations. Journal of Visualized Experiments 95: 52351.
29.
go back to reference Kelly, G.S. 1998. Clinical applications of N-acetylcysteine. Alternative Medicine Review : a journal of clinical therapeutic 3 (2): 114–127. Kelly, G.S. 1998. Clinical applications of N-acetylcysteine. Alternative Medicine Review : a journal of clinical therapeutic 3 (2): 114–127.
30.
go back to reference Schmaal, L., et al. 2011. Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. European Addiction Research 17 (4): 211–216.CrossRefPubMed Schmaal, L., et al. 2011. Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. European Addiction Research 17 (4): 211–216.CrossRefPubMed
31.
go back to reference MacNee, W. 2005. Oxidants and COPD. Current Drug Targets. Inflammation and Allergy 4 (6): 627–641.CrossRefPubMed MacNee, W. 2005. Oxidants and COPD. Current Drug Targets. Inflammation and Allergy 4 (6): 627–641.CrossRefPubMed
32.
go back to reference MacNee, W. 2005. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2 (1): 50–60.CrossRefPubMed MacNee, W. 2005. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2 (1): 50–60.CrossRefPubMed
33.
go back to reference Churg, A., M. Cosio, and J.L. Wright. 2008. Mechanisms of cigarette smoke-induced COPD: insights from animal models. American Journal of Physiology. Lung Cellular and Molecular Physiology 294 (4): L612–L631.CrossRefPubMed Churg, A., M. Cosio, and J.L. Wright. 2008. Mechanisms of cigarette smoke-induced COPD: insights from animal models. American Journal of Physiology. Lung Cellular and Molecular Physiology 294 (4): L612–L631.CrossRefPubMed
34.
go back to reference Puhakka, A., et al. 2003. High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS 111 (12): 1137–1146.CrossRefPubMed Puhakka, A., et al. 2003. High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS 111 (12): 1137–1146.CrossRefPubMed
35.
go back to reference Gaston, B., et al. 1994. The biology of nitrogen-oxides in the airways. American Journal of Respiratory and Critical Care Medicine 149 (2): 538–551.CrossRefPubMed Gaston, B., et al. 1994. The biology of nitrogen-oxides in the airways. American Journal of Respiratory and Critical Care Medicine 149 (2): 538–551.CrossRefPubMed
36.
go back to reference Soini, Y., et al. 2000. Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma. British Journal of Cancer 83 (7): 880–886.CrossRefPubMedPubMedCentral Soini, Y., et al. 2000. Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma. British Journal of Cancer 83 (7): 880–886.CrossRefPubMedPubMedCentral
37.
go back to reference Bowler, R.P., P.J. Barnes, and J.D. Crapo. 2004. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 1 (2): 255–277.CrossRefPubMed Bowler, R.P., P.J. Barnes, and J.D. Crapo. 2004. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 1 (2): 255–277.CrossRefPubMed
38.
go back to reference Al-Shukaili, A., et al. 2009. Effect of N-acetyl-L-cysteine on cytokine production by human peripheral blood mononuclear cells. Sultan Qaboos University Medical Journal 9 (1): 70–74.PubMedPubMedCentral Al-Shukaili, A., et al. 2009. Effect of N-acetyl-L-cysteine on cytokine production by human peripheral blood mononuclear cells. Sultan Qaboos University Medical Journal 9 (1): 70–74.PubMedPubMedCentral
39.
go back to reference Asami, S., et al. 1997. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 18 (9): 1763–1766.CrossRefPubMed Asami, S., et al. 1997. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 18 (9): 1763–1766.CrossRefPubMed
40.
go back to reference Albino, A.P., et al. 2004. Induction of H2AX phosphorylation in pulmonary cells by tobacco smoke: a new assay for carcinogens. Cell Cycle 3 (8): 1062–1068.CrossRefPubMed Albino, A.P., et al. 2004. Induction of H2AX phosphorylation in pulmonary cells by tobacco smoke: a new assay for carcinogens. Cell Cycle 3 (8): 1062–1068.CrossRefPubMed
41.
go back to reference Mian, M.F., et al. 2008. Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. Journal of Leukocyte Biology 83 (3): 774–784.CrossRefPubMed Mian, M.F., et al. 2008. Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. Journal of Leukocyte Biology 83 (3): 774–784.CrossRefPubMed
42.
go back to reference Trapani, J.A., and M.J. Smyth. 2002. Functional significance of the perforin/granzyme cell death pathway. Nature Reviews. Immunology 2 (10): 735–747.CrossRefPubMed Trapani, J.A., and M.J. Smyth. 2002. Functional significance of the perforin/granzyme cell death pathway. Nature Reviews. Immunology 2 (10): 735–747.CrossRefPubMed
43.
go back to reference van Dommelen, S.L., et al. 2006. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 25 (5): 835–848.CrossRefPubMed van Dommelen, S.L., et al. 2006. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 25 (5): 835–848.CrossRefPubMed
Metadata
Title
Role of Oxidative Stress in the Suppression of Immune Responses in Peripheral Blood Mononuclear Cells Exposed to Combustible Tobacco Product Preparation
Authors
Subhashini Arimilli
Eckhardt Schmidt
Brad E. Damratoski
G. L. Prasad
Publication date
01-10-2017
Publisher
Springer US
Published in
Inflammation / Issue 5/2017
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0602-9

Other articles of this Issue 5/2017

Inflammation 5/2017 Go to the issue